Human In Vivo Metabolism and Elimination Behavior of Micro-Dosed Selective Androgen Receptor Modulator RAD140 for

Felicitas Wagener1, Luisa Euler1, Christian Görgens1

  • 1Institute of Biochemistry/Center for Preventive Doping Research, German Sports University Cologne, Am Sportpark Müngersdorf 6, 50933 Cologne, Germany.

Metabolites
|July 27, 2022
PubMed

Insights

RAD140, a prohibited substance in sports, has its human metabolism and excretion studied. This research identifies key metabolites in urine, aiding the World Anti-Doping Agency in distinguishing between intentional doping and supplement contamination.

Area of Science:

  • Pharmacology
  • Analytical Chemistry
  • Sports Science

Background:

  • RAD140 is a selective androgen receptor modulator banned by the World Anti-Doping Agency (WADA).
  • Distinguishing RAD140 doping from dietary supplement contamination is challenging due to limited human metabolism data.

Purpose of the Study:

  • To investigate the metabolism and excretion of RAD140 in humans.
  • To identify RAD140 metabolites in urine for improved doping control.

Main Methods:

  • Six micro-dose excretion studies were conducted with adult male volunteers.
  • Urine samples were analyzed using Liquid Chromatography-High Resolution Mass Spectrometry (LC-HRMS/MS).
  • Enzymatic hydrolysis was used for sample preparation to estimate RAD140 concentrations.

Main Results:

  • Multiple novel metabolites of RAD140 were detected in human urine.
  • Elimination profiles and detection times for six metabolites and intact RAD140 were established.
  • Metabolite ratios showed potential for estimating RAD140 dosage.

Conclusions:

  • The study provides crucial data on RAD140 metabolism and excretion in humans.
  • Identified metabolites and analytical methods will enhance doping control and case management.
  • This research supports WADA's efforts in combating illicit substance use in sports.

Related Concept Videos

Drug Biotransformation: Overview01:16

Drug Biotransformation: Overview

Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.6K
Drug Metabolism: Phase I Reactions01:17

Drug Metabolism: Phase I Reactions

A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
3.5K
Factors Affecting Drug Biotransformation: Biological01:19

Factors Affecting Drug Biotransformation: Biological

Biological factors significantly impact drug metabolism, influencing drug clearance, efficacy, and potential toxicity.
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
224
Drug Metabolism: Phase II Reactions01:14

Drug Metabolism: Phase II Reactions

Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.0K
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance01:23

Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance

The elimination half-life and drug clearance of drugs following nonlinear kinetics can vary with dosage. The Michaelis-Menten parameters and drug concentration influence these factors. As the dose increases, the elimination half-life tends to lengthen, resulting in a reduction in clearance and a disproportionately larger area under the curve. The total clearance can be derived from the Michaelis-Menten equation for drugs following a one-compartment model.
A study on guinea pigs examined the...
288
Rational Dosage Regimen: Maintenance Dose and Loading Dose01:24

Rational Dosage Regimen: Maintenance Dose and Loading Dose

A rational dosage regimen considers a drug's pharmacokinetics, including its absorption, distribution, metabolism, and elimination from the body. By understanding these factors, the appropriate dosage can be determined, and the dosing schedule can be designed to achieve and maintain the desired therapeutic effect while minimizing adverse effects.
In most cases, drugs are administered repetitively or infused continuously to maintain a steady-state concentration in the body. At a steady...
4.4K